Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs

Influence of genetic variation inCYP3A4andABCB1on dose decrease or switching during simvastatin and atorvastatin therapy

(2009) Matthijs L. Becker et al.   PHARMACOEPIDEMIOLOGY AND DRUG SAFETY

Statin regulation of CYP3A4 and CYP3A5 expression

(2009) Maria Alice Vieira Willrich et al.   PHARMACOGENOMICS

Association of genotypes of the CYP3A cluster with midazolam disposition in vivo

(2009) J Miao et al.   PHARMACOGENOMICS JOURNAL

Influence of Friedreich Ataxia GAA Noncoding Repeat Expansions on Pre-mRNA Processing

(2008) Marco Baralle et al.   AMERICAN JOURNAL OF HUMAN GENETICS

Regulatory polymorphism in vitamin K epoxide reductase complex subunit 1 (VKORC1) affects gene expression and warfarin dose requirement

(2008) D. Wang et al.   BLOOD

Genotyping panel for assessing response to cancer chemotherapy

(2008) Zunyan Dai et al.   BMC Medical Genomics

CYP3A5⁎3A allele is associated with reduced lowering-lipid response to atorvastatin in individuals with hypercholesterolemia

(2008) Maria Alice V. Willrich et al.   CLINICA CHIMICA ACTA

CYP3A4*1G polymorphism is associated with lipid-lowering efficacy of atorvastatin but not of simvastatin

(2008) Yuan Gao et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Post-transcriptional Regulation of Human Pregnane X Receptor by Micro-RNA Affects the Expression of Cytochrome P450 3A4

(2008) Shingo Takagi et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

The Splicing Factor SF2/ASF Regulates Translation Initiation by Enhancing Phosphorylation of 4E-BP1

(2008) Gracjan Michlewski et al.   MOLECULAR CELL

Prediction of CYP3A4 enzyme activity using haplotype tag SNPs in African Americans

(2008) M A Perera et al.   PHARMACOGENOMICS JOURNAL

Contribution of cytochrome P450 3A4 and 3A5 to the metabolism of atorvastatin

(2008) J.-E. Park et al.   XENOBIOTICA